Feasibility and clinical value of circulating tumor DNA testing in patients with gastric adenocarcinomas

Gastric cancer is one of the leading causes of cancer worldwide, and this trend appears to be rising. Most patients are diagnosed at an advanced stage and thus prognosis is poor. Liquid biopsy, or circulating tumor DNA (ctDNA) testing, is emerging as a promising prognostic and/or predictive biomarke...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Gastrointest Oncol
Huvudupphovsmän: Iqbal, Madiha, Roberts, Ali, Starr, Jason, Mody, Kabir, Kasi, Pashtoon Murtaza
Materialtyp: Artigo
Språk:Inglês
Publicerad: AME Publishing Company 2019
Ämnen:
Special Report
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6534707/
https://ncbi.nlm.nih.gov/pubmed/31183188
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2019.01.14
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk